Orange SA and Bouygues SA are racing to reach an agreement on Orange’s purchase of Bouygues’ mobile-phone business in time for the boards of both companies to vote on the transaction Wednesday, according to people familiar with the matter.
The companies had set a goal of concluding a deal by Thursday, but hurdles remain and it’s possible the talks won’t succeed by the time the boards hold separate meetings tentatively scheduled for Wednesday, said the people, who asked not to be identified because the discussions are confidential. The talks may still end in failure, they said. Some Bouygues Telecom assets will be sold to France’s two other wireless carriers, Iliad SA and Numericable-SFR, in the transaction to avoid antitrust issues.
Discussions have been under way for months over a long-sought deal to reduce the number of mobile-phone companies in France to three from four. The talks, which would value Bouygues Telecom at about 10 billion euros, have been slow as the companies struggle to align the interests of all four parties, plus find an agreement on how big a stake in Orange the French government will retain, people with knowledge of the negotiations have said.
Full content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas